Synthesis and target annotation of the alkaloid GB18
Stone Woo and
Ryan A. Shenvi ()
Additional contact information
Stone Woo: Scripps Research
Ryan A. Shenvi: Scripps Research
Nature, 2022, vol. 606, issue 7916, 917-921
Abstract:
Abstract Ingestion of alkaloid metabolites from the bark of Galbulimima (GB) sp. leads to psychotropic and excitatory effects in humans1–4. Limited, variable supply of GB alkaloids5, however, has impeded their biological exploration and clinical development6. Here we report a solution to the supply of GB18, a structural outlier and putative psychotropic principle of Galbulimima bark. Efficient access to its challenging tetrahedral attached-ring motif required the development of a ligand-controlled endo-selective cross-electrophile coupling and a diastereoselective hydrogenation of a rotationally dynamic pyridine. Reliable, gram-scale access to GB18 enabled its assignment as a potent antagonist of κ- and μ-opioid receptors—the first new targets in 35 years—and lays the foundation to navigate and understand the biological activity of Galbulimima metabolites.
Date: 2022
References: Add references at CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.nature.com/articles/s41586-022-04840-9 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:606:y:2022:i:7916:d:10.1038_s41586-022-04840-9
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/s41586-022-04840-9
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().